期刊文献+

血清TPSA与F/T检测在前列腺良、恶性病变诊断中的价值及其影响因素 被引量:6

Value of serum total PSA and the ratio of free to total PSA in discriminating the benign and malignant prostatic disease and its influential factors
下载PDF
导出
摘要 目的:探讨血清总前列腺特异抗原(TPSA)、游离前列腺特异抗原(FPSA)检测及其比值(F/T)在BPH及前列腺癌(PCa)诊断中的应用价值,并观察各种因素对BPH患者TPSA值变化的影响。方法:对138例BPH患者及35例PCa患者血清TPSA、F/T的差异进行比较;另观察几种因素对298例BPH患者的影响作用。结果:总体比较两组间TPSA及F/T均有统计学意义;而在灰区(4μg/L<TPSA≤10μg/L),两组间TPSA差异无统计学意义,而只有F/T比值具有统计学意义(P<0. 01 );将临界值定为0. 15时,敏感性和特异性分别为85. 72%和77. 53%。在298例BPH患者中,年龄、前列腺大小、尿潴留、并发感染、结石等因素均对TPSA值有显著影响。结论:血清TPSA值测定仍为前列腺癌的重要诊断手段。但F/T值检测能更准确的鉴别位于灰区的病变性质。在TPSA异常增高的前列腺病变的诊断和鉴别诊断中应充分考虑各种影响因素。 Objective:To study the value of serum total PSA and the ratio of free to total PSA (F/T) in discriminating the benign and malignant prostatic disease and the influential factors to change the total PSA in patients benign prostatic hyperplasia (BPH).Methods:TPSA and F/T of 138 cases of BPH and 35 cases of prostatic cancer (PCa) were compared and the influential factor were studied in 298 cases of BPH.Results:The comparison of TPSA and F/T between total of the two kinds of diseases have statistical significance. But when TPSA were in the overlap (4~10 μg/L), only the comparison of F/T have statistical significance (P< 0.01). While the critical value of F/T was determined as 0.15, the sensitivity and specificity were 85.72% and 77.53% respectively. And in the 298 cases of BPH, age, size of prostate, urinary retention, infection and calculus have dramatic influence on TPSA.Conclusions:The determination of TPSA was the important method in diagnosis of prostate cancer. But in the overlap, F/T has more important role in discriminating the benign and malignant prostatic disease. Additionally, a few kinds of influential factors should be considered in dignosis of prostatic diseases with high TPSA.
出处 《临床泌尿外科杂志》 2005年第3期153-155,共3页 Journal of Clinical Urology
关键词 良性前列腺增生 前列腺肿瘤 前列腺特异抗原 Benign prostatic hyperplasia Prostatic neoplasma Prostatic specific antigen
  • 相关文献

参考文献6

  • 1周利群,陈为民,那彦群,黄有媛,冯陶,郝金瑞,潘柏年,薛兆英,顾方六,郭应禄.良性前列腺增生患者血清PSA与年龄变化的关系[J].中华泌尿外科杂志,2002,23(5):293-295. 被引量:38
  • 2Christensson A, Bjork J, Nilsson O,et al. Serum prostate specific antigen complexed to alpha t-antichymorrypsin as an indicator of prostate cancer. J Urol, 1993,150:100-105.
  • 3Jung K, Elgeti U, Lein M, et al. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA:which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Clinical Chem, 2000, 46:55-62.
  • 4Bunting P S, DeBoer G, Choo R, et al. Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation. Clin- Biochem, 2002, 35: 471 -475.
  • 5Khan M A, Carter H B, Epstein J I, et al. Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer? J Urol, 2003, 170:2274-22788.
  • 6Battikhi M N. Age-specific reference ranges for prostate-specific antigen (PSA) in jordanian patients. Prostate-Cancer-Prostatic-Dis, 2003, 6: 256 - 60.

二级参考文献8

  • 1Carter HB,Pearson JD,Metter EJ,et al.Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease[].The Journal of The American Medical Association.1992
  • 2Christensson A,Bjork T,Nilsson O,et al.Serum prostate specific antigen complexed to alpha1 - antichymotrypsin as an indicator of prostate cancer[].Journal d Urologie.1993
  • 3Oesterling JE,Jacobsen SJ,Chute CG,et al.Serum prostate-specific antigen in a commuinity-based population of healthy men[].The Journal of The American Medical Association.1993
  • 4Collins GN,Martin PJ,Wynn-Davies A,et al.The effect of dig-ital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free- to- total prostate specific antigen ratio in clinical practice[].Journal d Urologie.1997
  • 5Robles JM,Morell AR,Redorta JP,et al.Clinical behavior of prostate specific antigen and prostatic acid phosphotase: a comparative study[].European Urology.1988
  • 6Glenski WJ,Malek RS,Myrtle JF,et al.Sustained, sunstantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario[].Mayo Clinic Proceedings.1992
  • 7Brawer MK.Prostatic intraepithelial neoplasia and prostatic-specific antigen[].Urology.1989
  • 8Benson MC,Whang IS,Pantuck A,et al.Prostate specific antigen density: a means of distinguishing benign prostatic hypertraphy and prostate cancer[].Journal d Urologie.1992

共引文献37

同被引文献34

  • 1高中伟.血清PSA的影响因素[J].现代泌尿外科杂志,2001,6(2):60-62. 被引量:9
  • 2潘秀军,沈霞.前列腺特异性抗原比值(游离/总)在前列腺疾病诊断中的应用价值[J].检验医学,2005,20(2):89-91. 被引量:7
  • 3苏汉文,李艳,李栋.血清PSA系列在前列腺疾病中的应用[J].临床检验杂志,2005,23(2):137-138. 被引量:14
  • 4陈斌鸿,陈社安.复合型PSA与总PSA比值在前列腺癌诊断中的应用[J].中国实验诊断学,2005,9(2):210-212. 被引量:5
  • 5[1]Jung K,Stephan C,Elgeti U,et al.Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen《4mg/L:are they useful tools for early detection and screening of prostate cancer?[J].Int J Cancer,2001,93(5):759-765.
  • 6[3]Lee SE,Kwak C,Park MS,et al.Ethnic differences in the age related distribution of serum prostate specific antigen values:a study in a healthy Korean male population[J].Urology,2000,56(60):1007-1012.
  • 7[5]Khan MA,Carter HB,Epstein JI,et al.Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?[J].J Urol,2003,170(6):2274-2278.
  • 8Christensson A, Bjork T, Nilsson O, et al. Serum prostate specific antigen complexed to alpha 1-antichymortypsin as an indicator of prostate cancer. J Urol, 1993, 150(1) : 100-105.
  • 9Jung K, Elgeti U, Lein M, et al. Ratio of free or complexed prostate specific antigen ( PSA ) to total PSA : Which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Clin Chem, 2000, 46( 1 ) : 55-62.
  • 10Bunting PS, DeBoer G, Choo R, et al. Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation. Clin Biochem, 2002, 35(6): 471-475.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部